‪Pouria Rafsanjani Nejad‬ - ‪Google Scholar‬

Get my own profile

Cited by

	All	Since 2019
Citations	28	28
h-index	4	4
i10-index	0	0

0

14

7

2022202320245 13 10

Public access

4 articles

0 articles

available

not available

Based on funding mandates

Co-authors

Hossein TavanaThe University of AkronVerified email at uakron.edu
Astha LamichhanePost Doctoral Research FellowVerified email at uakron.edu
Pradip Shahi ThakuriThermoFisher ScientificVerified email at thermofisher.com
Gary LukerUniversity of MichiganVerified email at umich.edu
Nic D LeipzigRobert Iredell Associate Professor of Chemical and Biomolecular Engineering, The University of AkronVerified email at uakron.edu

Pouria Rafsanjani Nejad

Pouria Rafsanjani Nejad

Graduate Assistant

Verified email at uakron.edu

organ-on-chips cancer high throughput drug screening


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Therapeutic targeting of cancer stem cells prevents resistance of colorectal cancer cells to MEK inhibition A Lamichhane, P Shahi Thakuri, S Singh, P Rafsanjani Nejad, J Heiss, ... ACS Pharmacology & Translational Science 5 (9), 724-734, 2022	9	2022
Therapeutic targeting of stromal-tumor HGF-MET signaling in an organotypic triple-negative breast tumor model S Singh, A Lamichhane, P Rafsanjani Nejad, J Heiss, H Baumann, ... Molecular Cancer Research 20 (7), 1166-1177, 2022	9	2022
Modeling adaptive drug resistance of colorectal cancer and therapeutic interventions with tumor spheroids A Lamichhane, PS Thakuri, P Rafsanjani Nejad, H Tavana Experimental Biology and Medicine 246 (22), 2372-2380, 2021	6	2021
Toxicity of combinations of kinase pathway inhibitors to normal human cells in a three-dimensional culture P Rafsanjani Nejad, P Shahi Thakuri, S Singh, A Lamichhane, J Heiss, ... SLAS TECHNOLOGY: Translating Life Sciences Innovation 26 (3), 255-264, 2021	4	2021

The system can't perform the operation now. Try again later.

Articles 1–4